The GLP-1 Boom: A Drug Class Redefining the Obesity Market Welcome to Market Watch: Pharma, Biotech and Healthcare GLP-1 drugs have triggered one of the fastest commercial expansions in pharmaceutical history
So, the modern medical solution to this mismatch between the foods we were built to eat, that naturally activate satiety circuits, and the processed junk were now being sold is to physically, surgically change our anatomy to force it to the end of our gut, or inject GLP-1 mimicking drugs, so we get GLP-1 activation regardless of what we eat
Local rectal delivery in a gastrointestinal condition cannot be assumed to predict systemic exposure, tissue concentrations, effectiveness, or safety from an injection or oral product
Mickle AD, Shepherd AJ, Mohapatra DP